Dermira to Present at the 14th Annual Needham Healthcare Conference
April 08, 2015 07:30 ET
|
Dermira, Inc.
MENLO PARK, Calif., April 8, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists...
Dermira Reports Fourth Quarter and Full Year 2014 Financial Results and Provides Corporate Update
March 25, 2015 16:09 ET
|
Dermira, Inc.
DRM01 Phase 2b Trial in Acne to Start April 2015
Conference Call Today at 4:30 p.m. Eastern Time
MENLO PARK, Calif., March 25, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty...
Clinical Data for Dermira's DRM01 Acne Program Presented at Dermatology Meeting
March 23, 2015 07:00 ET
|
Dermira, Inc.
MENLO PARK, Calif., March 23, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists...
Dermira to Report Fourth Quarter and Full Year 2014 Financial Results
March 18, 2015 16:05 ET
|
Dermira, Inc.
MENLO PARK, Calif., March 18, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated dermatology products to...
Dermira Announces Late-Breaking Oral Presentation on DRM01 in Acne at 2015 AAD Annual Meeting
March 12, 2015 16:05 ET
|
Dermira, Inc.
MENLO PARK, Calif., March 12, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists...
Dermira Announces Positive Phase 2b Results for DRM04 in Patients With Hyperhidrosis
February 05, 2015 16:05 ET
|
Dermira, Inc.
MENLO PARK, Calif., Feb. 5, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and...
Dermira to Present at the 2015 Leerink Global Healthcare Conference
January 29, 2015 16:05 ET
|
Dermira, Inc.
MENLO PARK, Calif., Jan. 29, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists...
Dermira and UCB Announce Start of Phase 3 Program for CIMZIA(R) (certolizumab pegol) in Psoriasis
January 08, 2015 02:00 ET
|
Dermira, Inc.
Phase 3 program aims to address patient need for alternative treatment options in moderate-to-severe psoriasis
Program includes the first Phase 3 study in psoriasis comparing two...
Dermira Added to Russell 2000(R) Index
December 22, 2014 08:00 ET
|
Dermira, Inc.
MENLO PARK, Calif., Dec. 22, 2014 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated medical dermatology products...
Dermira Reports Third Quarter 2014 Financial Results and Provides Corporate Update
November 12, 2014 16:05 ET
|
Dermira, Inc.
REDWOOD CITY, Calif., Nov. 12, 2014 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated medical dermatology...